Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
News on Dr Reddys Laboratories
Market maintains bull run, experts remain bullish
4.29 pm | 24 Nov 2014 | Source: CNBC-TV18
Market expert Ambareesh Baliga believes market will move up over the next four-five days or one week. According to him, the appetite for such market i...
Dr. Reddy's launches Docetaxel Injection USP
12.02 pm | 24 Nov 2014 | Source: Moneycontrol.com
Dr Reddy’s Laboratories has launched Docetaxel Injection USP 20 mg/ml and 50 mg/ml a therapeutic equivalent generic version of TAXOTERE in the US mark...
Sun, Merck to dissolve branded generics JV?
7.17 pm | 14 Nov 2014 | Source: CNBC-TV18
Drug makers Sun Pharma and Merck may be heading to terminate their branded generics joint venture for emerging markets, reports Archana Shukla quoting...
Here are some stock picks from VK Sharma
9.20 am | 14 Nov 2014 | Source: CNBC-TV18
Watch the interview of VK Sharma of HDFC Securities with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his reading and outlook on ma...
Ranbaxy loses Valcyte exclusivity: An analysis
10.14 am | 07 Nov 2014 | Source: CNBC-TV18
Ranbaxy has first-to-file status, meaning eligibility for six months of generic sales exclusivity for both AstraZeneca's heartburn drug Nexium & Roche...
Quick Links for Dr Reddys Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.